Aurinia Pharmaceuticals Inc Ordinary Shares (NASDAQ: AUPH) last traded at $16.65, down 3.59% on the session. The quote above updates while this page is open; the figures below are drawn from Aurinia Pharmaceuticals Inc Ordinary Shares’s own filings and are restated only when a new one is published.
Aurinia Pharmaceuticals Inc Ordinary Shares trades on NASDAQ under the ticker AUPH. Its market capitalisation is $2.22 billion.
Valuation measures for Aurinia Pharmaceuticals Inc Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.22B |
|---|---|
| Enterprise value | $2.21B |
| P/E ratio | 7.27 |
| Price / sales | 7.11 |
| Price / book | 3.60 |
| Beta | 0.68 |
Trailing-twelve-month figures tagged in Aurinia Pharmaceuticals Inc Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $311.51M |
|---|---|
| Net income (TTM) | $314.11M |
| EPS (TTM) | $2.29 |
| Operating margin | 48.39% |
| Return on equity | 51.09% |
| Cash | $179.73M |
Range and volume for AUPH over the past 52 weeks.
| 52-week high | $19.25 |
|---|---|
| 52-week low | $10.34 |
| Volume | 1.25M |
| Average volume | 1.49M |
| Previous close | $17.27 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.